Figure 2From: Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study Changes in median eGFR at 0, 4, 8, 12, 24, 36, and 48 weeks in TDF+PI/r and control groups. Back to article page